olokizumab (OKZ)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for olokizumab (OKZ), covering 2021-04-30 to 2021-04-30. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease [Phase 3]